DNA X, Inc. Balance Sheet
SONM|6 years of annual SEC 10-K data (FY2019-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 6 fiscal years. All figures from audited SEC 10-K filings.
DNA X, Inc. had $40M in total assets and $22M in shareholders' equity as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $5.3M | $9.4M | $13.2M | $22.1M | $22.1M | $11.3M |
| Accounts Receivable | $4.3M | $25.3M | $22.4M | $4.2M | $4.6M | $10.1M |
| Inventory | $10.6M | $6.5M | $3.9M | $11.3M | $11.3M | $19.5M |
| Current Assets | $32.2M | $43.8M | $43.6M | $45.6M | $45.6M | $47.3M |
| PP&E (Net) | $227.0K | $71.0K | $168.0K | $843.0K | $843.0K | $1.4M |
| Total Assets | $39.7M | $56.0M | $53.7M | $50.3M | $50.3M | $55.5M |
| Current Liabilities | $43.7M | $32.1M | $32.1M | $20.5M | $20.5M | $27.6M |
| Total Debt | - | - | - | $185.0K | $185.0K | $10.2M |
| Shareholders' Equity | $22.4M | $20.0M | $18.6M | $25.5M | $25.5M | $5.1M |